Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/21/2000US6150366 Crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles with specific particle size are useful as antipsychosis agent
11/21/2000US6150346 Method and composition for treating or preventing osteoporosis
11/21/2000US6150341 Reacting the 5'oh group of vb12 or an analogue thereof with a bifunctional carbonyl electrophile to form an active intermediate, and subsequently reacting the intermediate with a nucleophilic spacer molecule to yield vb12 derivative
11/21/2000US6150331 Human growth hormone-containing aqueous pharmaceutical composition
11/21/2000US6150086 Preparing composition; inserting fats, oils and oil soluble substances into cellulose solution, solidifying solution and confining fats, oils and oil soluble subatances, adding second polymer to further confine substance
11/21/2000US6149953 For use in baking bromate-free bakery products such as bread; for conditioning dough
11/21/2000US6149947 Compositions of oak bark extract related synthetic compositions and method of using same
11/21/2000US6149944 Mixing aqueous phase containing water-soluble betalactam antibiotic agent and/or inhibitor of betalactamase and organic phase comprising biodegradable polymer is dissolved in solvent, dispersing, adding to aqueous phase; desolventizing
11/21/2000US6149943 Active drug is layered onto tcore via solution coating; coated particles have arrower particle size distribution
11/21/2000US6149942 Pharmaceutical pellet formulation
11/21/2000US6149941 Taste of active pharmaceutical ingredients
11/21/2000US6149940 Bioavailability; on contact with gastric juices, after rapid and considerable swelling of layers increases considerably in volume, thus, the pharmaceutical preparation remains in the stomach for longer; drug delivery, time release agents
11/21/2000US6149938 Process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets and compositions obtained thereby
11/21/2000US6149937 Selecting amphiphilic compound ionic species of which will partly insert into liposomal phospholipid bilayers by numeric molecular modelling or conformational analysis; extracting hydrophilic ionic species; preparing lipid film and suspension
11/21/2000US6149935 Solid matrix system for transdermal drug delivery
11/21/2000US6149933 Supplies useful nutrients for hair growth, development, and pigmentation
11/21/2000US6149908 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating Helicobacter pylori infection
11/21/2000US6149893 Pharmaceutical compositions containing calcitonin in a spray dosing feeder for intranasal administration
11/21/2000US6149892 Metered dose inhaler for beclomethasone dipropionate
11/21/2000CA2187202C Multilamellar drug delivery systems
11/21/2000CA2159452C Needleless syringe using supersonic gas flow for particle delivery
11/21/2000CA2098294C Directly compressible xylitol and method
11/21/2000CA2081482C Method and composition for treatment of central nervous system disease states associated with abnormal amyloid beta protein molecular organization
11/21/2000CA2054189C Stable ascorbic acid compositions
11/21/2000CA2038578C Delivery of agents
11/21/2000CA2031150C Sustained-release drug dosage units
11/21/2000CA2024631C Double-coated granules of disodium pamidronate
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/21/2000CA2010085C Pentamidine solutions
11/18/2000CA2684454A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
11/16/2000WO2000068080A1 Method and device for producing flat-bed seal-edge bags containing a preparation with a gas producer and a seal-edge bag produced according to the inventive method
11/16/2000WO2000067917A1 Permeabilizing biofilms
11/16/2000WO2000067892A1 Method and device for forming particles
11/16/2000WO2000067889A1 W/o type emulsions with a high water content containing medium polar lipids
11/16/2000WO2000067800A2 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
11/16/2000WO2000067799A1 Compositions for treatment of disorders of the oesophagus
11/16/2000WO2000067797A1 Composition providing a sustained release of l-histidine and methods of manufacture thereof
11/16/2000WO2000067779A2 Polymerized liposomes for the delivery of mammalian growth hormone
11/16/2000WO2000067773A2 Combinations of immunosupressive agents for the treatment or prevention of graft rejections
11/16/2000WO2000067772A1 Galenic formulations of argatroban for subcutaneous administration
11/16/2000WO2000067766A1 Restorative and regenerative preparation, method for producing the same and therapeutical use according to l.v. dubinina
11/16/2000WO2000067760A1 Liposome preparation of fat-soluble antitumor drug
11/16/2000WO2000067753A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
11/16/2000WO2000067747A1 Docusate hard gelatin capsules
11/16/2000WO2000067730A1 Drug delivery device
11/16/2000WO2000067729A1 Regimen and kit for amelioration of premature ejaculation
11/16/2000WO2000067728A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000WO2000067727A1 Galenic formulations of antithrombotic agents for subcutaneous administration
11/16/2000WO2000067725A1 Gastroretentive system with capillaries
11/16/2000WO2000067724A2 Gastroretentive system for an extended retention time in the stomach or in the gastro-intestinal tract
11/16/2000WO2000067723A2 Form of administration for applying in body orifices
11/16/2000WO2000067706A1 Pack agent in sheet form
11/16/2000WO2000067702A1 Cosmetic or pharmaceutical utilisation of nanoscalic metal soaps
11/16/2000WO2000067694A1 A method and apparatus for manufacturing dissolvable tablets
11/16/2000WO2000067684A1 Intrauterine contraceptive device
11/16/2000WO2000067595A1 Rapidly disintegrating flavor wafer for flavor enrichment
11/16/2000WO2000056336A3 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
11/16/2000WO2000053228A3 Use of niaouli essential oil as transdermal permeation enhancer
11/16/2000WO2000044406A3 Dna vaccines against hantavirus infections
11/16/2000WO2000044389A3 Method for preparing membrane vesicles
11/16/2000WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease
11/16/2000WO2000038625A3 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants
11/16/2000WO2000037057A3 Novel formulations comprising lipid-regulating agents
11/16/2000WO2000033825A3 Compositions and methods for amelioration of human female sexual dysfunction
11/16/2000WO2000032186A3 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/16/2000WO2000032174A3 Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide
11/16/2000WO2000027887A3 Cross-linked hyaluronic acids and medical uses thereof
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000WO2000018316A3 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
11/16/2000WO2000006138A3 Use of moclobemide for treating pain and other diseases
11/16/2000WO2000000157A3 Use of tempo and tempo derivatives for inducing cell death
11/16/2000DE19922537A1 Darreichungsform zur Applikation in Körperöffnungen Dosage form for application in body openings
11/16/2000DE19922368A1 New hybrid polymer composition, useful as carrier for controlled drug release, comprising water-soluble polymers and silicon oxide units bonded via polymerizable groups
11/16/2000DE19922193A1 Stable, solubilizer-free, water-dilutable essential oil concentrate formulation, useful e.g. in pharmaceutical, cosmetic or food applications, comprising liposomes based on hydrogenated lecithin
11/16/2000DE19921693A1 Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
11/16/2000DE19920853A1 Gastroretentive system for oral administration comprises porous capsule containing swellable polymer, useful for active agent administration or volume reduction of stomach contents
11/16/2000DE19920838A1 Gastroretentives System mit Kapillaren Gastroretentive system with capillaries
11/16/2000DE19920837A1 Gastroretentives System für verlängerte Verweilzeit im Magen bzw. im Gastrointestinaltrakt Gastroretentive system for prolonged residence time in the stomach or in the gastrointestinal tract
11/16/2000DE19920836A1 Oral dosage form for controlled release of gastrointestinal active agent comprises layered unit adapted to prevent or retard pyloric passage during gastric erosion
11/16/2000DE19920835A1 Verfahren und Vorrichtung zur Herstellung von Flachbett-Siegelrandbeuteln, enthaltend eine Zubereitung mit einem Gasbildner sowie ein nach dem Verfahren hergestellter Siegelrandbeutel Method and device for producing flat-bed-side-sealed bags containing a preparation having a gas forming agent, and a sealed bags made by the method
11/16/2000DE19920833A1 Swallowable gastro-retentive drug release system, e.g. for treating gastritis or gastric ulcers, which swells or foams in contact with gastric fluid to be retained in stomach or intestines for predetermined period
11/16/2000DE19920555A1 Verwendung von nanoskaligen Metallseifen The use of nanoscale metal soaps
11/16/2000DE10021266A1 Hergestellte Artikel mit Phosphodiesterase-Inhibitor Produced with Article phosphodiesterase inhibitor
11/16/2000CA2373447A1 Permeabilizing biofilms
11/16/2000CA2372461A1 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates
11/16/2000CA2371263A1 Intrauterine contraceptive device
11/16/2000CA2369594A1 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
11/16/2000CA2369328A1 Drug delivery device
11/16/2000CA2368087A1 Method and device for forming particles
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051979A1 Use of peroxidised lipids to prevent and/or treat the irritating effect of an active agent
11/15/2000EP1051978A1 Crystallographically stable amorphous cephalosporin compositions and process for producing the same
11/15/2000EP1051977A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition
11/15/2000EP1051976A2 Use of bisphosphate for the treatment of osteogenesis imperfecta
11/15/2000EP1051975A1 Dry mix formulation for bisphosphonic acids
11/15/2000EP1051974A1 Lotions containing vitamin d 3 derivatives
11/15/2000EP1051972A1 Nitric oxide donor composition and method for treatment of anal disorders
11/15/2000EP1051971A1 Patch and method for transdermal delivery of bupropion base
11/15/2000EP1051969A1 Coated antibiotic granules
11/15/2000EP1051451A1 An article having a surface showing adhesive properties
1 ... 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 ... 2991